🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
MariMed Inc. (MRMD)
OTCMKTS · Delayed Price · Currency is USD
0.0471
-0.0019 (-3.88%)
At close: Nov 20, 2026

MariMed Statistics

Total Valuation

MariMed has a market cap or net worth of 19.12 million. The enterprise value is 104.26 million.

Market Cap19.12M
Enterprise Value 104.26M

Important Dates

The last earnings date was Wednesday, November 11, 2026.

Earnings Date Nov 11, 2026
Ex-Dividend Date n/a

Share Statistics

MariMed has 406.00 million shares outstanding. The number of shares has increased by 3.17% in one year.

Current Share Class 406.00M
Shares Outstanding 406.00M
Shares Change (YoY) +3.17%
Shares Change (QoQ) +0.85%
Owned by Insiders (%) 10.78%
Owned by Institutions (%) 0.00%
Float 338.61M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.11
PB Ratio 0.46
P/TBV Ratio 6.36
P/FCF Ratio 2.09
P/OCF Ratio 1.90
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.86, with an EV/FCF ratio of 11.41.

EV / Earnings n/a
EV / Sales 0.62
EV / EBITDA 8.86
EV / EBIT n/a
EV / FCF 11.41

Financial Position

The company has a current ratio of 0.90, with a Debt / Equity ratio of 1.93.

Current Ratio 0.90
Quick Ratio 0.29
Debt / Equity 1.93
Debt / EBITDA 7.69
Debt / FCF 9.91
Interest Coverage -0.27

Financial Efficiency

Return on equity (ROE) is -26.66% and return on invested capital (ROIC) is -1.74%.

Return on Equity (ROE) -26.66%
Return on Assets (ROA) -0.70%
Return on Invested Capital (ROIC) -1.74%
Return on Capital Employed (ROCE) -1.69%
Weighted Average Cost of Capital (WACC) 8.10%
Revenue Per Employee 193,167
Profits Per Employee -17,910
Employee Count923
Asset Turnover 0.83
Inventory Turnover 2.79

Taxes

In the past 12 months, MariMed has paid 4.73 million in taxes.

Income Tax 4.73M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -41.13% in the last 52 weeks. The beta is 1.55, so MariMed's price volatility has been higher than the market average.

Beta (5Y) 1.55
52-Week Price Change -41.13%
50-Day Moving Average 0.06
200-Day Moving Average 0.07
Relative Strength Index (RSI) 34.03
Average Volume (20 Days) 1,034,395

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 0.02

Income Statement

In the last 12 months, MariMed had revenue of 167.28 million and -15.51 million in losses. Loss per share was -0.04.

Revenue167.28M
Gross Profit 59.16M
Operating Income -2.20M
Pretax Income -10.74M
Net Income -15.51M
EBITDA 9.61M
EBIT -2.20M
Loss Per Share -0.04
Full Income Statement

Balance Sheet

The company has 10.36 million in cash and 90.49 million in debt, with a net cash position of -80.12 million or -0.20 per share.

Cash & Cash Equivalents 10.36M
Total Debt 90.49M
Net Cash -80.12M
Net Cash Per Share -0.20
Equity (Book Value) 46.99M
Book Value Per Share 0.10
Working Capital -6.59M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 10.08 million and capital expenditures -949,000, giving a free cash flow of 9.13 million.

Operating Cash Flow 10.08M
Capital Expenditures -949,000
Depreciation & Amortization 11.81M
Net Borrowing -4.43M
Free Cash Flow 9.13M
FCF Per Share 0.02
Full Cash Flow Statement

Margins

Gross margin is 35.37%, with operating and profit margins of -1.32% and -9.27%.

Gross Margin 35.37%
Operating Margin -1.32%
Pretax Margin -6.42%
Profit Margin -9.27%
EBITDA Margin 5.74%
EBIT Margin -1.32%
FCF Margin 5.46%

Dividends & Yields

MariMed does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -3.17%
Shareholder Yield -3.17%
Earnings Yield -84.93%
FCF Yield 47.77%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

MariMed has an Altman Z-Score of -0.08 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -0.08
Piotroski F-Score 3